One of the best-studied therapeutic vaccines in PDAC is GVAX (granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-modified tumor vaccine), which contains irradiated whole pancreatic tumor cells unable to grow that have been genetically modified to secrete GM-CSF. Here, CSF2 is linked to pancreatic neoplasm.